U.S. markets closed
  • S&P 500

    4,166.45
    -55.41 (-1.31%)
     
  • Dow 30

    33,290.08
    -533.37 (-1.58%)
     
  • Nasdaq

    14,030.38
    -130.97 (-0.92%)
     
  • Russell 2000

    2,237.75
    -49.71 (-2.17%)
     
  • Crude Oil

    71.50
    +0.46 (+0.65%)
     
  • Gold

    1,763.90
    -10.90 (-0.61%)
     
  • Silver

    25.84
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1865
    -0.0045 (-0.38%)
     
  • 10-Yr Bond

    1.4500
    -0.0610 (-4.04%)
     
  • GBP/USD

    1.3809
    -0.0115 (-0.83%)
     
  • USD/JPY

    110.1500
    -0.0810 (-0.07%)
     
  • BTC-USD

    35,617.70
    -2,104.89 (-5.58%)
     
  • CMC Crypto 200

    887.34
    -52.60 (-5.60%)
     
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • Nikkei 225

    28,964.08
    -54.25 (-0.19%)
     

Pfizer lifts FY adjusted profit forecast on Hospira buy

Sept 30 (Reuters) - Drugmaker Pfizer Inc raised its full-year revenue and adjusted profit forecast to reflect its recently closed deal for hospital products maker Hospira Inc.

Pfizer now expects 2015 revenue in the range of $46.5 billion to $47.5 billion, up from its previous estimate of $45.0 billion to $46.0 billion.

The drugmaker also raised both ends of its adjusted profit forecast by 3 cents, to $2.04-$2.10 per share.

(Reporting by Natalie Grover in Bengaluru; Editing by Shounak Dasgupta)